DE
GILD icon

DV Equities’s Gilead Sciences GILD Stock Holding History

DV Equities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$215K Buy
+1,751
New +$213K 0.04% 130

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

DV Equities's GILD Position: Q4 2025 in Review

DV Equities opened a new position in Gilead Sciences (GILD) in Q4 2025: 1,751 shares worth $215K. The stake represents 0.04% of the portfolio and ranks #130 among its holdings.

2,219 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • DV Equities held 1,751 shares of Gilead Sciences worth $215K as of Q4 2025.
  • Gilead Sciences was a new DV Equities position in Q4 2025.
  • Gilead Sciences made up 0.04% of DV Equities's portfolio in Q4 2025, its #130 holding.
  • 2,219 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.